{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:53:52Z","timestamp":1761155632262},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":9503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1093\/annonc\/5.suppl_2.s113","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:54:55Z","timestamp":1353362095000},"page":"S113-S115","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S2","title":["Hodgkin's disease in children: Combined modality treatment for stages IA, IB, and IIA"],"prefix":"10.1016","volume":"5","author":[{"given":"G.","family":"Schellong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Br\u00e4mswig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"H\u00f6rnig-Franz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.W.","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"P\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wannenmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0005","first-page":"703","article-title":"Chemotherapy combined with involved-field irradiation for 177 children with Hodgkin\u2019s disease","volume":"33","author":"Balwierz","year":"1991","journal-title":"Acta Paed (Jpn)"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0010","first-page":"329","article-title":"Radiation induced thyroid dysfunction in pediatric Hodgkin\u2019s disease: Comparison between patients with and without diagnostic lymphangiography","volume":"15","author":"Bramswig","year":"1987","journal-title":"Med Ped Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0015","first-page":"344","article-title":"Ovarian function in 63 girls treated for Hodgkin\u2019s disease according to the West German DAL-HD-78, and DAL-HD-82 therapy studies","volume":"17","author":"Br\u00e4mswig","year":"1989","journal-title":"Med Ped Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0020","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/1097-0142(19900315)65:6<1298::AID-CNCR2820650607>3.0.CO;2-W","article-title":"The effect of different cumulative doses of chemotherapy on testicular function: Results in 75 patients treated for Hodgkin\u2019s disease during childhood or adolescence","volume":"65","author":"Br\u00e4mswig","year":"1990","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/10428199009050994","article-title":"The challenge of pediatric Hodgkin\u2019s disease: Where is the balance between cure and long-term toxicity? A report of the West German multicenter studies DAL-HD-78, DAL-HD-82, and DAL-HD-85","volume":"3","author":"Br\u00e4mswig","year":"1990","journal-title":"Leukemia and Lymphoma"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0030","first-page":"101","article-title":"Testicular function in boys after treatment for Hodgkin\u2019s disease with or without procarbazine","volume":"101","author":"Br\u00e4mswig","year":"1993","journal-title":"Exp Clin Endocrinol"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-2007-1025440","article-title":"Testikul\u00e4re Funktion nach OPA\/COMP-Chemotherapie ohne Procarbazin bei Jungen und M\u00e4dchen mit Morbus Hodgkin","volume":"203","author":"Hassel","year":"1991","journal-title":"Klin P\u00e4diat"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0040","first-page":"477","article-title":"Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin\u2019s disease: The experience of the French Society of Pediatric Oncology","volume":"17","author":"Oberlin","year":"1992","journal-title":"Med Ped Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/annonc\/3.suppl_4.S73","article-title":"Treatment of children with Hodgkin\u2019s disease: Results of the German Pediatric Oncology Group","volume":"4","author":"Schellong","year":"1992","journal-title":"Oncol Ann"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0050","first-page":"41","article-title":"An approach to reduce treatment and invasive staging in childhood Hodgkin\u2019s disease: The sequence of the German DAL multicenter studies","volume":"75","author":"Schellong","year":"1988","journal-title":"Bull Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0055","first-page":"205","article-title":"Risk factor adapted treatment of Hodgkin\u2019s lymphoma in childhood: Strategies and results of three consecutive multicenter studies in the Federal Republic of Germany","volume":"117","author":"Schellong","year":"1989","journal-title":"In Diehl V, Pfreundschuh M, Loeffler M (eds): New aspects in the treatment of Hodgkin\u2019s disease. Recent Results in Cancer Research"},{"key":"10.1093\/annonc\/5.suppl_2.S113_bb0060","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/1097-0142(19860515)57:10<2049::AID-CNCR2820571029>3.0.CO;2-9","article-title":"Prediction of splenic involvement in children with Hodgkin\u2019s disease: Significance of clinical and intraoperative findings \u2014 a retrospective statistical analysis of 154 patients in the German therapy study DAL-HD-78","volume":"57","author":"Schellong","year":"1986","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/5\/suppl_2\/S113\/6679244\/5-suppl_2-S113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:15:45Z","timestamp":1589537745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419633867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":12,"alternative-id":["S0923753419633867"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/5.suppl_2.s113","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1994]]}}}